Antitrust Featured Generic Drugs Greg Curfman Health Law Policy Intellectual Property Pharmaceuticals Public Health 3 Challenges to Patents on Therapeutic Monoclonal Antibodies Read more: 3 Challenges to Patents on Therapeutic Monoclonal Antibodies